Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

EPA:DIM - Euronext Paris - Matif - FR0013154002 - Common Stock - Currency: EUR

203.7  -2 (-0.97%)

Fundamental Rating

5

DIM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. DIM has an average financial health and profitability rating. DIM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

DIM had positive earnings in the past year.
In the past year DIM had a positive cash flow from operations.
In the past 5 years DIM has always been profitable.
In the past 5 years DIM always reported a positive cash flow from operatings.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

DIM's Return On Assets of 2.46% is in line compared to the rest of the industry. DIM outperforms 52.63% of its industry peers.
With a Return On Equity value of 5.14%, DIM perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
DIM has a worse Return On Invested Capital (4.36%) than 63.16% of its industry peers.
DIM had an Average Return On Invested Capital over the past 3 years of 10.41%. This is above the industry average of 7.38%.
The 3 year average ROIC (10.41%) for DIM is well above the current ROIC(4.36%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.46%
ROE 5.14%
ROIC 4.36%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

DIM has a better Profit Margin (7.15%) than 68.42% of its industry peers.
DIM's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 14.05%, DIM perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
DIM's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 43.89%, DIM is doing good in the industry, outperforming 63.16% of the companies in the same industry.
DIM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.05%
PM (TTM) 7.15%
GM 43.89%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

DIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DIM has more shares outstanding
Compared to 5 years ago, DIM has more shares outstanding
Compared to 1 year ago, DIM has an improved debt to assets ratio.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

DIM has an Altman-Z score of 4.06. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
DIM has a better Altman-Z score (4.06) than 84.21% of its industry peers.
The Debt to FCF ratio of DIM is 5.03, which is a neutral value as it means it would take DIM, 5.03 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.03, DIM perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
DIM has a Debt/Equity ratio of 0.72. This is a neutral value indicating DIM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.72, DIM is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 5.03
Altman-Z 4.06
ROIC/WACC0.51
WACC8.53%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.85 indicates that DIM should not have too much problems paying its short term obligations.
DIM has a Current ratio of 1.85. This is in the better half of the industry: DIM outperforms 68.42% of its industry peers.
DIM has a Quick Ratio of 1.14. This is a normal value and indicates that DIM is financially healthy and should not expect problems in meeting its short term obligations.
DIM has a Quick ratio (1.14) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.14
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.97% over the past year.
Measured over the past 5 years, DIM shows a small growth in Earnings Per Share. The EPS has been growing by 4.19% on average per year.
DIM shows a small growth in Revenue. In the last year, the Revenue has grown by 5.21%.
DIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.05% yearly.
EPS 1Y (TTM)4.97%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%34.88%
Revenue 1Y (TTM)5.21%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%11.65%

3.2 Future

The Earnings Per Share is expected to grow by 21.45% on average over the next years. This is a very strong growth
Based on estimates for the next years, DIM will show a quite strong growth in Revenue. The Revenue will grow by 10.39% on average per year.
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y21.45%
Revenue Next Year8.49%
Revenue Next 2Y9.67%
Revenue Next 3Y10.37%
Revenue Next 5Y10.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 53.61 indicates a quite expensive valuation of DIM.
DIM's Price/Earnings ratio is a bit more expensive when compared to the industry. DIM is more expensive than 78.95% of the companies in the same industry.
DIM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 36.95 indicates a quite expensive valuation of DIM.
78.95% of the companies in the same industry are cheaper than DIM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DIM to the average of the S&P500 Index (21.76), we can say DIM is valued expensively.
Industry RankSector Rank
PE 53.61
Fwd PE 36.95
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

78.95% of the companies in the same industry are cheaper than DIM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DIM is valued a bit more expensive than the industry average as 63.16% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 33.97
EV/EBITDA 31.27
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as DIM's earnings are expected to grow with 24.81% in the coming years.
PEG (NY)2.24
PEG (5Y)12.78
EPS Next 2Y25.51%
EPS Next 3Y24.81%

More info and screens

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.34%, DIM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.72, DIM has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.34%

5.2 History

The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

DIM pays out 32.84% of its income as dividend. This is a sustainable payout ratio.
DIM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP32.84%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (7/11/2025, 7:00:00 PM)

203.7

-2 (-0.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-16 2025-04-16/bmo
Earnings (Next)07-22 2025-07-22
Inst Owners10.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.83B
Analysts77.78
Price Target242.84 (19.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.34%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP32.84%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.91%
Min EPS beat(2)7.63%
Max EPS beat(2)22.18%
EPS beat(4)2
Avg EPS beat(4)0.98%
Min EPS beat(4)-20.27%
Max EPS beat(4)22.18%
EPS beat(8)2
Avg EPS beat(8)-16.9%
EPS beat(12)2
Avg EPS beat(12)-16.88%
EPS beat(16)5
Avg EPS beat(16)-11.85%
Revenue beat(2)2
Avg Revenue beat(2)3.21%
Min Revenue beat(2)2.91%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)-1.35%
Revenue beat(12)4
Avg Revenue beat(12)-1.7%
Revenue beat(16)8
Avg Revenue beat(16)12.23%
PT rev (1m)-2.24%
PT rev (3m)-5.38%
EPS NQ rev (1m)2.28%
EPS NQ rev (3m)2.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.49%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-5.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 53.61
Fwd PE 36.95
P/S 6.94
P/FCF 33.97
P/OCF 22.54
P/B 4.99
P/tB N/A
EV/EBITDA 31.27
EPS(TTM)3.8
EY1.87%
EPS(NY)5.51
Fwd EY2.71%
FCF(TTM)6
FCFY2.94%
OCF(TTM)9.04
OCFY4.44%
SpS29.36
BVpS40.81
TBVpS-5.43
PEG (NY)2.24
PEG (5Y)12.78
Profitability
Industry RankSector Rank
ROA 2.46%
ROE 5.14%
ROCE 5.47%
ROIC 4.36%
ROICexc 4.84%
ROICexgc 15.14%
OM 14.05%
PM (TTM) 7.15%
GM 43.89%
FCFM 20.42%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 5.03
Debt/EBITDA 4
Cap/Depr 95.85%
Cap/Sales 10.35%
Interest Coverage 2.25
Cash Conversion 123.84%
Profit Quality 285.66%
Current Ratio 1.85
Quick Ratio 1.14
Altman-Z 4.06
F-Score7
WACC8.53%
ROIC/WACC0.51
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)4.97%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%34.88%
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y21.45%
Revenue 1Y (TTM)5.21%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%11.65%
Revenue Next Year8.49%
Revenue Next 2Y9.67%
Revenue Next 3Y10.37%
Revenue Next 5Y10.39%
EBIT growth 1Y-0.84%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year91.76%
EBIT Next 3Y37.04%
EBIT Next 5Y27.34%
FCF growth 1Y325.99%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y45.08%
OCF growth 3Y5.11%
OCF growth 5Y21.32%